National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

bromodeoxyuridine
A halogenated thymidine analogue with potential antineoplastic and radiosensitizing activities. Bromodeoxyuridine competes with thymidine for incorporation into DNA, resulting in DNA mutation and the inhibition of cell proliferation. As a radiosensitizer, this agent is associated with the inhibition of repair of radiation-induced DNA double-strand breaks (DSBs). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:5-bromodeoxyuridine
broxuridine
Abbreviations:5-BrdU
BrdU
Chemical structure name:5-bromouracil-2-deoxyriboside



Previous:brivanib alaninate, broad-spectrum human papillomavirus vaccine V505, broccoli sprout extract, bromelain, bromocriptine mesylate
Next:bromovinyl-deoxyuridine, brostallicin, bruceantin, bryostatin 1, budesonide/formoterol fumarate dihydrate inhalation aerosol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov